ANSEL'S
PHARMACEUTICAL
DOSAGE FORMS AND
DRUG DELIVERY
SYSTEMS, 12TH EDITION
By Loyd V. Allen Jr.,
Ph.D., R.Ph. and Timothy
B. McPherson, Ph.D.
COMPLETE TEST BANK |
CHAPTERS 1-21 | LATEST
2025/2026
,Table of Contents
ANSEL'S PHARMACEUTICAL DOSAGE FORMS AND DRUG DELIVERY SYSTEMS, 12TH EDITION ...... 1
By Loyd V. Allen Jr., Ph.D., R.Ph . and Timothy B. McPherson, Ph.D. ................................................... 1
COMPLETE TEST BANK | CHAPTERS 1-21 | LATEST 2025/2026 ...................................................... 1
SECTION I: INTRODUCTION TO DRUGS, DRUG DOSAGE FORMS, AND DRUG DELIVERY SYSTEMS 5
Chapter 1: Introduction to Drugs and Pharmacy .................................................................................. 5
Keywords............................................................................................................................................... 5
Chapter 1 Key Takeaways................................................................................................................ 14
Chapter 2: New Drug Development and Approval Process ............................................................... 15
Keywords............................................................................................................................................. 15
Chapter 2 Key Takeaways................................................................................................................ 25
Chapter 3: Current Good Manufacturing Practices and Current Good Compounding Practices .... 25
Keywords............................................................................................................................................. 25
Chapter 3 Key Takeaways................................................................................................................ 35
SECTION II: DRUG DOSAGE FORM AND DRUG DELIVERY SYSTEM DESIGN ................................... 35
Chapter 4: Dosage Form Design: Pharmaceutical and Formulation Considerations ....................... 35
Keywords............................................................................................................................................. 36
Chapter 4 Key Takeaways................................................................................................................ 45
Chapter 5: Dosage Form Design: Biopharmaceutical and Pharmacokinetic Considerations.......... 45
Keywords............................................................................................................................................. 45
Chapter 5 Key Takeaways................................................................................................................ 54
SECTION III: SOLID DOSAGE FORMS AND SOLID MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
................................................................................................................................................................ 55
Chapter 6: Powders and Granules........................................................................................................ 55
Keywords............................................................................................................................................. 55
Chapter 6 Key Takeaways................................................................................................................ 64
Chapter 7: Capsules ............................................................................................................................... 65
Keywords............................................................................................................................................. 65
Chapter 7 Key Takeaways................................................................................................................ 74
Chapter 8: Tablets ................................................................................................................................. 75
, Keywords............................................................................................................................................. 75
Chapter 8 Key Takeaways................................................................................................................ 84
Chapter 9: Solid Oral Modified-Release Dosage Forms and Drug Delivery Systems ....................... 85
Keywords............................................................................................................................................. 85
Chapter 9 Key Takeaways................................................................................................................ 94
SECTION IV: SEMISOLID DOSAGE FORMS AND TRANSDERMAL SYSTEMS .................................... 95
Chapter 10: Ointments, Creams, and Gels ........................................................................................... 95
Keywords............................................................................................................................................. 95
Chapter 10 Key Takeaways............................................................................................................ 104
Chapter 11: Transdermals and Transdermal Drug Delivery Systems ............................................ 105
Keywords........................................................................................................................................... 105
Chapter 11 Key Takeaways............................................................................................................ 114
SECTION V: SUPPOSITORIES, INSERTS, AND MEDICATION STICKS .............................................. 115
Chapter 12: Suppositories, Inserts, and Medication Sticks .............................................................. 115
Keywords........................................................................................................................................... 115
Chapter 12 Key Takeaways............................................................................................................ 124
SECTION VI: LIQUID DOSAGE FORMS ............................................................................................... 124
Chapter 13: Solutions .......................................................................................................................... 124
Keywords........................................................................................................................................... 125
Chapter 13 Key Takeaways............................................................................................................ 133
Chapter 14: Disperse Systems ............................................................................................................ 134
Keywords........................................................................................................................................... 134
Chapter 14 Key Takeaways............................................................................................................ 143
SECTION VII: STERILE DOSAGE FORMS AND DELIVERY SYSTEMS ............................................... 143
Chapter 15: Parenterals ...................................................................................................................... 143
Keywords........................................................................................................................................... 143
Chapter 15 Key Takeaways............................................................................................................ 152
Chapter 16: Biologics .......................................................................................................................... 153
Keywords........................................................................................................................................... 153
Chapter 16 Key Takeaways............................................................................................................ 163
Chapter 17: Special Solutions and Suspensions................................................................................ 164
Keywords........................................................................................................................................... 164
, Chapter 17 Key Takeaways............................................................................................................ 173
Chapter 18: Radiopharmaceuticals .................................................................................................... 174
Keywords........................................................................................................................................... 174
Chapter 18 Key Takeaways............................................................................................................ 183
Chapter 19: Products of Biotechnology ............................................................................................. 184
Keywords........................................................................................................................................... 184
Chapter 19 Key Takeaways............................................................................................................ 194
Chapter 20: Novel Dosage Forms and Drug Delivery Technologies................................................ 194
Keywords........................................................................................................................................... 195
Chapter 20 Key Takeaways............................................................................................................ 204
Chapter 21: Clinical Pharmaceutics ................................................................................................... 205
Keywords........................................................................................................................................... 205
Chapter 21 Key Takeaways............................................................................................................ 215
PHARMACEUTICAL
DOSAGE FORMS AND
DRUG DELIVERY
SYSTEMS, 12TH EDITION
By Loyd V. Allen Jr.,
Ph.D., R.Ph. and Timothy
B. McPherson, Ph.D.
COMPLETE TEST BANK |
CHAPTERS 1-21 | LATEST
2025/2026
,Table of Contents
ANSEL'S PHARMACEUTICAL DOSAGE FORMS AND DRUG DELIVERY SYSTEMS, 12TH EDITION ...... 1
By Loyd V. Allen Jr., Ph.D., R.Ph . and Timothy B. McPherson, Ph.D. ................................................... 1
COMPLETE TEST BANK | CHAPTERS 1-21 | LATEST 2025/2026 ...................................................... 1
SECTION I: INTRODUCTION TO DRUGS, DRUG DOSAGE FORMS, AND DRUG DELIVERY SYSTEMS 5
Chapter 1: Introduction to Drugs and Pharmacy .................................................................................. 5
Keywords............................................................................................................................................... 5
Chapter 1 Key Takeaways................................................................................................................ 14
Chapter 2: New Drug Development and Approval Process ............................................................... 15
Keywords............................................................................................................................................. 15
Chapter 2 Key Takeaways................................................................................................................ 25
Chapter 3: Current Good Manufacturing Practices and Current Good Compounding Practices .... 25
Keywords............................................................................................................................................. 25
Chapter 3 Key Takeaways................................................................................................................ 35
SECTION II: DRUG DOSAGE FORM AND DRUG DELIVERY SYSTEM DESIGN ................................... 35
Chapter 4: Dosage Form Design: Pharmaceutical and Formulation Considerations ....................... 35
Keywords............................................................................................................................................. 36
Chapter 4 Key Takeaways................................................................................................................ 45
Chapter 5: Dosage Form Design: Biopharmaceutical and Pharmacokinetic Considerations.......... 45
Keywords............................................................................................................................................. 45
Chapter 5 Key Takeaways................................................................................................................ 54
SECTION III: SOLID DOSAGE FORMS AND SOLID MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
................................................................................................................................................................ 55
Chapter 6: Powders and Granules........................................................................................................ 55
Keywords............................................................................................................................................. 55
Chapter 6 Key Takeaways................................................................................................................ 64
Chapter 7: Capsules ............................................................................................................................... 65
Keywords............................................................................................................................................. 65
Chapter 7 Key Takeaways................................................................................................................ 74
Chapter 8: Tablets ................................................................................................................................. 75
, Keywords............................................................................................................................................. 75
Chapter 8 Key Takeaways................................................................................................................ 84
Chapter 9: Solid Oral Modified-Release Dosage Forms and Drug Delivery Systems ....................... 85
Keywords............................................................................................................................................. 85
Chapter 9 Key Takeaways................................................................................................................ 94
SECTION IV: SEMISOLID DOSAGE FORMS AND TRANSDERMAL SYSTEMS .................................... 95
Chapter 10: Ointments, Creams, and Gels ........................................................................................... 95
Keywords............................................................................................................................................. 95
Chapter 10 Key Takeaways............................................................................................................ 104
Chapter 11: Transdermals and Transdermal Drug Delivery Systems ............................................ 105
Keywords........................................................................................................................................... 105
Chapter 11 Key Takeaways............................................................................................................ 114
SECTION V: SUPPOSITORIES, INSERTS, AND MEDICATION STICKS .............................................. 115
Chapter 12: Suppositories, Inserts, and Medication Sticks .............................................................. 115
Keywords........................................................................................................................................... 115
Chapter 12 Key Takeaways............................................................................................................ 124
SECTION VI: LIQUID DOSAGE FORMS ............................................................................................... 124
Chapter 13: Solutions .......................................................................................................................... 124
Keywords........................................................................................................................................... 125
Chapter 13 Key Takeaways............................................................................................................ 133
Chapter 14: Disperse Systems ............................................................................................................ 134
Keywords........................................................................................................................................... 134
Chapter 14 Key Takeaways............................................................................................................ 143
SECTION VII: STERILE DOSAGE FORMS AND DELIVERY SYSTEMS ............................................... 143
Chapter 15: Parenterals ...................................................................................................................... 143
Keywords........................................................................................................................................... 143
Chapter 15 Key Takeaways............................................................................................................ 152
Chapter 16: Biologics .......................................................................................................................... 153
Keywords........................................................................................................................................... 153
Chapter 16 Key Takeaways............................................................................................................ 163
Chapter 17: Special Solutions and Suspensions................................................................................ 164
Keywords........................................................................................................................................... 164
, Chapter 17 Key Takeaways............................................................................................................ 173
Chapter 18: Radiopharmaceuticals .................................................................................................... 174
Keywords........................................................................................................................................... 174
Chapter 18 Key Takeaways............................................................................................................ 183
Chapter 19: Products of Biotechnology ............................................................................................. 184
Keywords........................................................................................................................................... 184
Chapter 19 Key Takeaways............................................................................................................ 194
Chapter 20: Novel Dosage Forms and Drug Delivery Technologies................................................ 194
Keywords........................................................................................................................................... 195
Chapter 20 Key Takeaways............................................................................................................ 204
Chapter 21: Clinical Pharmaceutics ................................................................................................... 205
Keywords........................................................................................................................................... 205
Chapter 21 Key Takeaways............................................................................................................ 215
